CXCL12 and CXCL13 may serve as biomarkers for assessing RSV bronchiolitis severity and predicting recurrence, aiding early clinical evaluation and prognosis. The gene discussed is CXCL12; the disease is respiratory syncytial virus bronchiolitis.